AMAG Pharmaceuticals (AMAG)

AMAG Pharmaceuticals' (AMAG) CEO William Heiden on Q1 2018 Results - Earnings Call Transcript
May 3, 2018 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals (AMAG) CEO Bill Heiden on Q4 2017 Results - Earnings Call Transcript
Feb. 27, 2018 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals (AMAG) CEO Bill Heiden on Q3 2017 Results - Earnings Call Transcript
Nov. 5, 2017 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO Bill Heiden on Q2 2017 Results - Earnings Call Transcript
Aug. 3, 2017 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO Bill Heiden on Q1 2017 Results - Earnings Call Transcript
May 2, 2017 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO Bill Heiden on Q4 2016 Results - Earnings Call Transcript
Feb. 14, 2017 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO Bill Heiden on Q3 2016 Results - Earnings Call Transcript
Nov. 4, 2016 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO Bill Heiden on Q2 2016 Results - Earnings Call Transcript
Aug. 10, 2016 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO William Heiden Presents at Deutsche Bank 41st Annual Health Care C
May 5, 2016 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO Bill Heiden on Q1 2016 Results - Earnings Call Transcript
May 3, 2016 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals (AMAG) Q4 2015 Results - Earnings Call Webcast
Feb. 17, 2016 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO Bill Heiden on Q4 2015 Results - Earnings Call Transcript
Feb. 17, 2016 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals (AMAG) Q3 2015 Results - Earnings Call Webcast
Nov. 3, 2015 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO William HeidenonQ3 2015 Results - Earnings Call Transcript
Nov. 3, 2015 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO William Heiden on Q2 2015 Results - Earnings Call Transcript
July 23, 2015 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals (AMAG) Q1 2015 Results - Earnings Call Webcast
May 5, 2015 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO Bill Heiden on Q1 2015 Results - Earnings Call Transcript
May 5, 2015 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO Bill Heiden on Q4 2014 Results - Earnings Call Transcript
Feb. 9, 2015 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals (AMAG) Q4 2014 Results - Earnings Call Webcast
Feb. 9, 2015 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO William Heiden on Q3 2014 Results - Earnings Call Transcript
Nov. 2, 2014 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals (AMAG) Q3 2014 Results - Earnings Call Webcast
Oct. 30, 2014 | Price: Free! | Source: Seeking Alpha

Q2 2014 Amag Pharmaceuticals In Earnings Conference Call (Webcast)
July 29, 2014 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO Bill Heiden on Q2 2014 Results - Earnings Call Transcript
July 29, 2014 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' CEO Discusses Q1 2014 Results - Earnings Call Transcript
April 26, 2014 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals's CEO Discusses Q4 2013 Results - Earnings Call Transcript
Feb. 6, 2014 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' CEO Host's host Corporate Conference Call To Provide A Regulatory Update (Tra
Jan. 22, 2014 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' CEO Presents at 32nd Annual J.P. Morgan Healthcare Conference (Transcript)
Jan. 15, 2014 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals, Inc. Q3 2013 Earnings Conference Call Transcript
Oct. 23, 2013 | Price: $106.00 | Source: Thomson

AMAG Pharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript
Oct. 23, 2013 | Price: Free! | Source: Seeking Alpha

AMAG Conferenca Call to discuss the PDUFA date extension Transcript
Oct. 17, 2013 | Price: $106.00 | Source: Thomson

AMAG Pharmaceuticals' CEO Discusses PDUFA Date Extension Conference Call (Transcript)
Oct. 17, 2013 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals, Inc. at Morgan Stanley Healthcare Conference Transcript
Sept. 9, 2013 | Price: $54.00 | Source: Thomson

AMAG Pharmaceuticals Management Presents at Morgan Stanley Global Healthcare Conference (Transcript
Sept. 9, 2013 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' CEO Discusses Q2 2013 Results - Earnings Call Transcript
Aug. 2, 2013 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals, Inc. Q2 2013 Earnings Conference Call Transcript
Aug. 1, 2013 | Price: $106.00 | Source: Thomson

AMAG Pharmaceuticals' CEO Discusses Q1 2013 (Results - Earnings Call Transcript
April 23, 2013 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals, Inc. Q1 2013 Earnings Conference Call Transcript
April 23, 2013 | Price: $106.00 | Source: Thomson

AMAG Pharmaceuticals' CEO Presents at Positive Preliminary Results from IDA-303 Study Conference (T
March 15, 2013 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals Inc Conference Call to Discuss Positive Preliminary Results from IDA-303 Study
March 15, 2013 | Price: $106.00 | Source: Thomson

AMAG Pharmaceuticals, Inc. at Cowen Health Care Conference Transcript
March 4, 2013 | Price: $54.00 | Source: Thomson

AMAG Pharmaceuticals, Inc. at JPMorgan Global Healthcare Conference (Q and A Session) Transcript
Jan. 9, 2013 | Price: $54.00 | Source: Thomson

AMAG Pharmaceuticals, Inc. at JPMorgan Global Healthcare Conference Transcript
Jan. 9, 2013 | Price: $54.00 | Source: Thomson

AMAG's CEO Presents at J.P. Morgan Global Healthcare Conference (Transcript)
Jan. 9, 2013 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' COO Presents at Lazard Capital Markets 9th Annual Healthcare Conference (Tran
Nov. 13, 2012 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals, Inc. Q3 2012 Earnings Conference Call Transcript
Nov. 1, 2012 | Price: $106.00 | Source: Thomson

AMAG Pharmaceuticals' CEO Discusses Q3 Results - Earnings Call Transcript
Nov. 1, 2012 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' CEO Presents at Morgan Stanley Healthcare Conference (Transcript)
Sept. 10, 2012 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals, Inc. at Morgan Stanley Healthcare Conference Transcript
Sept. 10, 2012 | Price: $54.00 | Source: Thomson

AMAG Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript
July 26, 2012 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals, Inc. Q2 2012 Earnings Conference Call Transcript
July 26, 2012 | Price: $54.00 | Source: Thomson

AMAG Pharmaceuticals, Inc.(AMAG) Q2 2012 Earnings Call Transcript
July 26, 2012 | Price: Free! | Source: Morningstar

AMAG Pharmaceuticals' CEO Presents IDA-301 Data (Transcript)
July 20, 2012 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals IDA-301 Data Conference Call Transcript
July 18, 2012 | Price: $54.00 | Source: Thomson

AMAG Pharmaceuticals, Inc. at Goldman Sachs Healthcare Conference Transcript
June 6, 2012 | Price: $54.00 | Source: Thomson

AMAG Pharmaceuticals, Inc.(AMAG) Q1 2012 Earnings Call Transcript
May 1, 2012 | Price: Free! | Source: Morningstar

AMAG Pharmaceuticals, Inc.(AMAG) Q4 2011 Earnings Call Transcript
March 5, 2012 | Price: Free! | Source: Morningstar

AMAG Pharmaceuticals, Inc.(AMAG) Q3 2011 Earnings Call Transcript
Nov. 4, 2011 | Price: Free! | Source: Morningstar

AMAG Pharmaceuticals, Inc.(AMAG) Q2 2011 Earnings Call Transcript
July 26, 2011 | Price: Free! | Source: Morningstar

AMAG Pharmaceuticals, Inc.(AMAG) Q1 2011 Earnings Call Transcript
May 3, 2011 | Price: Free! | Source: Morningstar

AMAG Pharmaceuticals CEO Discusses Q3 2010 Results - Earnings Call Transcript
Oct. 29, 2010 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals, Inc. Q2 2010 Earnings Call Transcript
July 29, 2010 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals Inc. Q1 2010 Earnings Call Transcript
April 28, 2010 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals, Inc. Q1 2009 Earnings Call Transcript
April 30, 2009 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals Inc. Q4 2008 Earnings Call Transcript
Feb. 27, 2009 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
Nov. 3, 2008 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals Inc. Q2 2008 Earnings Call Transcript
July 29, 2008 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals Inc. Q1 2008 Earnings Call Transcript
June 23, 2008 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals Inc. Q4 2007 Earnings Call Transcript
Feb. 21, 2008 | Price: Free! | Source: Seeking Alpha

Recent filings

Confidential treatment order - Sept. 11, 2018

EVP of AMAG Pharmaceuticals just disposed of 1,473 shares - Aug. 27, 2018

AMAG Pharmaceuticals Just Filed Its Quarterly Report: BASIC AND DILUTED NE... - Aug. 3, 2018

Automatic shelf registration statement of securities of well-known seasoned issuers - June 13, 2018

AMAG Pharmaceuticals director just picked up 3,578 shares - June 8, 2018

AMAG Pharmaceuticals director just picked up 3,578 shares - June 8, 2018

AMAG Pharmaceuticals director just picked up 3,578 shares - June 8, 2018

AMAG Pharmaceuticals's President & CEO just disposed of 20,000 shares - June 5, 2018

Amag Pharmaceuticals Announces First Quarter 2018 Financial Results AND RAISES FULL YEAR FINANCIAL GUIDANCE - May 3, 2018

EVP of AMAG Pharmaceuticals just declared 0 ownership of the company. - May 2, 2018

EVP of AMAG Pharmaceuticals just picked up 28,418 shares - May 2, 2018

AMAG Pharmaceuticals releases salary data. CEO sees compensation rise 43% - April 25, 2018

Steven Boyd just provided an update on share ownership of AMAG Pharmaceuticals - April 5, 2018

On March - March 23, 2018

EVP of AMAG Pharmaceuticals just picked up 19,350 shares - March 6, 2018

AMAG Pharmaceuticals's Chief Human Resources Officer just picked up 14,451 shares - March 6, 2018

AMAG Pharmaceuticals's Chief Financial Officer just picked up 19,146 shares - March 6, 2018

AMAG Pharmaceuticals's President & CEO just picked up 80,454 shares - March 6, 2018

EVP of AMAG Pharmaceuticals just picked up 23,300 shares - March 6, 2018

AMAG Pharmaceuticals's Chief Commercial Officer just picked up 17,807 shares - March 6, 2018

AMAG Pharmaceuticals Just Filed Its Annual Report: The following is a s... - March 1, 2018

AMAG: Financial Results And Company Update GAAP Revenue Increased - Feb. 27, 2018

Amag Pharmaceuticals Announces Fda Approval Of - Feb. 15, 2018

Stephen DuBois Not applicable just provided an update on share ownership of AMAG Pharmaceuticals - Feb. 14, 2018

STATE STREET CORPORATION just provided an update on share ownership of AMAG Pharmaceuticals - Feb. 14, 2018

The Vanguard Group just provided an update on share ownership of AMAG Pharmaceuticals - Feb. 8, 2018

Janus Capital Management LLC EIN just provided an update on share ownership of AMAG Pharmaceuticals - Feb. 6, 2018

Amag Pharmaceuticals Announces Fda Approval Of Supplemental New Drug Application (Snda) For Feraheme - Feb. 5, 2018

Confidential treatment order - Feb. 1, 2018

BlackRock, Inc. just provided an update on share ownership of AMAG Pharmaceuticals - Jan. 23, 2018

Amag Pharmaceuticals Announces Preliminary 2017 Financial Results - Jan. 8, 2018

AMAG Pharmaceuticals's Chief Human Resources Officer just declared owning 42,155 shares of AMAG Pharmaceuticals - Dec. 5, 2017

Departure of Directors or Certain - Nov. 30, 2017

AMAG Pharmaceuticals Just Filed Its Quarterly Report: The following is a s... - Nov. 6, 2017

Amag Pharmaceuticals Announces Third Quarter 2017 Financial Results AND BUSINESS HIGHLIGHTS Intrarosa - Nov. 2, 2017

Departure of Directors or Certain - Sept. 13, 2017

SVP of AMAG Pharmaceuticals just disposed of 1,250 shares - Aug. 30, 2017

SVP of AMAG Pharmaceuticals just disposed of 1,633 shares - Aug. 28, 2017

AMAG Pharmaceuticals Just Filed Its Quarterly Report: BASIC AND DILUTED NE... - Aug. 4, 2017

Amag Pharmaceuticals Announces Second Quarter 2017 Financial Results AND PROVIDES CORPORATE UPDATE - Aug. 3, 2017

Stephen DuBois Not applicable just provided an update on share ownership of AMAG Pharmaceuticals - July 31, 2017

SVP Clinical & Regulatory of AMAG Pharmaceuticals just disposed of 4,938 shares - July 14, 2017

Statement of acquisition of beneficial ownership by individuals - July 10, 2017

Securities to be offered to employees in employee benefit plans - June 23, 2017

SVP Clinical & Regulatory of AMAG Pharmaceuticals just disposed of 3,503 shares - June 5, 2017

Stephen DuBois Not applicable just provided an update on share ownership of AMAG Pharmaceuticals - May 25, 2017

Current report, items 5.02, 5.07, 7.01, and 9.01 - May 24, 2017

AMAG Pharmaceuticals director just picked up 4,545 shares - May 22, 2017

AMAG Pharmaceuticals director just picked up 4,545 shares - May 22, 2017

AMAG Pharmaceuticals director just picked up 4,545 shares - May 22, 2017

AMAG Pharmaceuticals director just picked up 4,545 shares - May 22, 2017

AMAG Pharmaceuticals director just picked up 4,545 shares - May 22, 2017

AMAG Pharmaceuticals director just picked up 4,545 shares - May 22, 2017

AMAG Pharmaceuticals director just picked up 4,545 shares - May 22, 2017

AMAG Pharmaceuticals director just picked up 4,545 shares - May 22, 2017

Stephen DuBois Not applicable just provided an update on share ownership of AMAG Pharmaceuticals - May 15, 2017

Entry into a Material Definitive - May 15, 2017

SVP of AMAG Pharmaceuticals just disposed of 980 shares - May 10, 2017

AMAG Pharmaceuticals's Chief Commercial Officer just disposed of 3,483 shares - May 10, 2017

AMAG Pharmaceuticals's President & CEO just disposed of 19,085 shares - May 10, 2017

AMAG Pharmaceuticals's Chief Financial Officer just disposed of 2,177 shares - May 10, 2017

Filing under Securities Act Rules 163/433 of free writing prospectuses - May 8, 2017

AMAG Pharmaceuticals just filed a prospectus, suggesting it plans to soon issue some securities - May 8, 2017

Amag Pharmaceuticals Announces Proposed Offering Of $250 Million Of Convertible Senior Notes Due 2022 - May 8, 2017

Filing under Securities Act Rules 163/433 of free writing prospectuses - May 5, 2017

AMAG Pharmaceuticals just filed a prospectus, suggesting it plans to soon issue some securities - May 3, 2017

AMAG Pharmaceuticals Just Filed Its Quarterly Report: BASIC AND DILUTED NE... - May 3, 2017

Filing [Trust Indenture Act] - May 3, 2017

For purposes of the registration statement on - May 3, 2017

Filing under Securities Act Rules 163/433 of free writing prospectuses - May 3, 2017

Amag Pharmaceuticals Announces First Quarter 2017 Financial Results AND PROVIDES CORPORATE UPDATE - May 2, 2017

SVP Clinical & Regulatory of AMAG Pharmaceuticals just disposed of 1,891 shares - May 2, 2017

AMAG Pharmaceuticals releases salary data. CEO sees compensation fall -19% - April 20, 2017

Material Modification to Rights of Security - April 10, 2017

Registration of securities [Section 12(b)] - April 10, 2017

Other preliminary proxy statements - April 10, 2017

Amag Pharmaceuticals Announces Closing Of Exclusive Licensing Agreement With Endoceutics For U.S. Rights To INTRAROSA  (PRASTERONE) - April 5, 2017

Confidential treatment order - March 20, 2017

Amag Announces Management Changes And New Commercial Appointments - March 6, 2017

AMAG Pharmaceuticals's President & COO just picked up 24,000 shares - Feb. 27, 2017

SVP of AMAG Pharmaceuticals just picked up 15,000 shares - Feb. 27, 2017

AMAG Pharmaceuticals's Chief Commercial Officer just picked up 20,000 shares - Feb. 27, 2017

AMAG Pharmaceuticals's Chief Financial Officer just picked up 15,000 shares - Feb. 27, 2017

AMAG Pharmaceuticals's CEO just picked up 85,000 shares - Feb. 27, 2017

SVP Clinical & Regulatory of AMAG Pharmaceuticals just picked up 15,000 shares - Feb. 27, 2017

AMAG Pharmaceuticals Just Filed Its Annual Report: Basic and Diluted Ne... - Feb. 21, 2017

Amag Reports Fourth Quarter And Full Year Financial Results - Feb. 14, 2017

Steven A. Cohen just provided an update on share ownership of AMAG Pharmaceuticals - Feb. 14, 2017

Janus Capital Management LLC EIN just provided an update on share ownership of AMAG Pharmaceuticals - Feb. 13, 2017

STATE STREET CORPORATION just provided an update on share ownership of AMAG Pharmaceuticals - Feb. 10, 2017

Westfield Capital Management Company, LP just issued a filing suggesting it has sold all of its AMAG Pharmaceuticals - Feb. 10, 2017

The Vanguard Group just provided an update on share ownership of AMAG Pharmaceuticals - Feb. 9, 2017

Phillip Gross just provided an update on share ownership of AMAG Pharmaceuticals - Feb. 9, 2017

Amag Pharmaceuticals Announces Closing Of Exclusive Licensing Agreement For North American Rights To Rekynda  (BREMELANOTIDE) - Feb. 3, 2017

Palo Alto Healthcare Master Fund II, L.P. just provided an update on share ownership of AMAG Pharmaceuticals - Jan. 12, 2017

BlackRock, Inc. just provided an update on share ownership of AMAG Pharmaceuticals - Jan. 12, 2017

Amag Pharmaceuticals Provides Financial And Business Update - Jan. 9, 2017

AMAG Pharmaceuticals director just declared 0 ownership of the company. - Dec. 22, 2016

AMAG Pharmaceuticals director just picked up 1,026 shares - Dec. 22, 2016

Amag Pharmaceuticals Announces Appointment Of Brian Kelley To Board Of Directors - Dec. 22, 2016

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. STEELHEAD PARTNERS LLC 49,265,000 3.8 June 30, 2018
2. CNH PARTNERS LLC 33,575,000 0.4 Dec. 31, 2017
3. Citadel Advisors LLC 32,050,900 N/A Sept. 30, 2017
4. WOLVERINE ASSET MANAGEMENT LLC 31,236,500 0.3 June 30, 2018
5. CAMDEN ASSET MANAGEMENT L P /CA 25,875,000 0.8 June 30, 2018
6. Allianz Asset Management AG 23,000,000 N/A June 30, 2018
7. Allianz Asset Management AG 23,000,000 N/A June 30, 2018
8. TENOR CAPITAL MANAGEMENT Co., L.P. 22,600,000 1.5 Dec. 31, 2017
9. DEERFIELD MANAGEMENT CO 16,250,000 0.7 Sept. 30, 2017
10. DEUTSCHE BANK AG\ 14,652,789 N/A March 31, 2018
11. DEUTSCHE BANK AG\ 13,263,160 N/A Dec. 31, 2017
12. Citadel Advisors LLC 12,319,942 N/A March 31, 2018
13. UBS Group AG 11,672,779 N/A Dec. 31, 2017
14. WATER ISLAND CAPITAL LLC 11,000,000 0.6 June 30, 2018
15. Calamos Advisors LLC 10,000,000 0.1 June 30, 2018
16. UBS Group AG 9,564,390 N/A March 31, 2018
17. UBS Group AG 9,564,390 N/A March 31, 2018
18. JPMORGAN CHASE & CO 9,081,381 N/A Dec. 31, 2017
19. Context Capital Management, LLC 8,800,000 7.6 June 30, 2018
20. Telemetry Investments, L.L.C. 8,250,000 2.3 Dec. 31, 2017
21. CITIGROUP INC 7,930,106 N/A June 30, 2018
22. Birch Grove Capital LP 7,424,000 3.5 June 30, 2018
23. JPMORGAN CHASE & CO 7,395,166 N/A Sept. 30, 2017
24. BlackRock Inc. 6,388,539 N/A Dec. 31, 2017
25. DEUTSCHE BANK AG\ 5,824,859 N/A June 30, 2018
26. DEUTSCHE BANK AG\ 5,824,859 N/A June 30, 2018
27. DEUTSCHE BANK AG\ 5,824,859 N/A June 30, 2018
28. BlackRock Inc. 5,650,354 N/A June 30, 2017
29. Bruce & Co., Inc. 5,500,000 1.1 June 30, 2018
30. SSI INVESTMENT MANAGEMENT INC 5,500,000 0.4 June 30, 2018

AMAG Pharmaceuticals (AMAG)

140
 


Feedback